Literature DB >> 11788893

Clinical significance of lens culinaris agglutinin-reactive fraction of serum alpha-fetoprotein in patients with hepatocellular carcinoma.

Shuhei Yoshida1, Kazutaka Kurokohchi, Keiji Arima, Tsutomu Masaki, Naoki Hosomi, Toshiharu Funaki, Masayuki Murota, Yuko Kita, Seishiro Watanabe, Shigeki Kuriyama.   

Abstract

alpha-fetoprotein (AFP) is an important marker for the diagnosis of hepatocellular carcinoma (HCC) and has been widely used in clinical settings. Recently, the importance of lens culinaris agglutinin-reactive fraction of AFP (AFP-L3) has been indicated. However, the clinical significance of the level of AFP-L3 protein in relation to the characteristics of HCC has not been fully evaluated. In the present study, both the ratio of AFP-L3 (AFP-L3%) and the absolute value of AFP-L3 (AFP-L3-AV) were examined in 80 patients with HCC, and evaluated with respect to characteristics of HCC such as grade of differentiation, size of tumor and morphological findings. Among HCC-specific tumor markers, AFP, AFP-L3% and protein induced in vitamin K absence (PIVKA-II), AFP showed the highest positive rate in patients with HCC, while AFP-L3% showed the lowest rate. AFP-L3% and AFP-L3-AV were, however, most significantly correlated with the grade of HCC differentiation, while AFP showed the least significant correlation. Furthermore, AFP-L3% was most significantly correlated with the size of HCC in patients with solitary HCC. Conversely, neither AFP-L3-AV nor PIVKA-II showed a significant correlation with the size of HCC. In relation to morphological differences of HCC, although AFP-L3%, AFP-L3-AV and PIVKA-II were significantly higher in the diffuse type of HCC than in the nodular type of HCC, AFP was most significantly correlated with the morphological differences of HCC. These results indicate that tumor markers for HCC, such as AFP, AFP-L3%, AFP-L3-AV and PIVKA-II, may play different roles in predicting the characteristics of HCC.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11788893

Source DB:  PubMed          Journal:  Int J Oncol        ISSN: 1019-6439            Impact factor:   5.650


  11 in total

1.  Glycylproline dipeptidyl aminopeptidase isoenzyme in diagnosis of primary hepatocellular carcinoma.

Authors:  Run-Zhou Ni; Jie-Fei Huang; Ming-Bing Xiao; Mei Li; Xian-Yong Meng
Journal:  World J Gastroenterol       Date:  2003-04       Impact factor: 5.742

2.  Effects of tachyplesin on proliferation and differentiation of human hepatocellular carcinoma SMMC-7721 cells.

Authors:  Gao-Liang Ouyang; Qi-Fu Li; Xuan-Xian Peng; Qing-Rong Liu; Shui-Gen Hong
Journal:  World J Gastroenterol       Date:  2002-12       Impact factor: 5.742

3.  Diffuse intrahepatic recurrence after percutaneous radiofrequency ablation for solitary and small hepatocellular carcinoma.

Authors:  Yoshiyuki Mori; Hideyuki Tamai; Naoki Shingaki; Kosaku Moribata; Tatsuya Shiraki; Hisanobu Deguchi; Kazuki Ueda; Shotaro Enomoto; Hiroto Magari; Izumi Inoue; Takao Maekita; Mikitaka Iguchi; Kimihiko Yanaoka; Masashi Oka; Masao Ichinose
Journal:  Hepatol Int       Date:  2009-04-29       Impact factor: 6.047

4.  Evaluation of midkine as a diagnostic serum biomarker in hepatocellular carcinoma.

Authors:  Wen-Wei Zhu; Jia-Jian Guo; Lei Guo; Hu-Liang Jia; Ming Zhu; Ju-Bo Zhang; Christopher A Loffredo; Marshonna Forgues; Hua Huang; Xu-Jian Xing; Ning Ren; Qiong-Zhu Dong; Hai-Jun Zhou; Zheng-Gang Ren; Nai-Qing Zhao; Xin Wei Wang; Zhao-You Tang; Lun-Xiu Qin; Qing-Hai Ye
Journal:  Clin Cancer Res       Date:  2013-05-29       Impact factor: 12.531

Review 5.  Circulating specific biomarkers in diagnosis of hepatocellular carcinoma and its metastasis monitoring.

Authors:  Li Wang; Min Yao; Zhizhen Dong; Yun Zhang; Dengfu Yao
Journal:  Tumour Biol       Date:  2013-09-05

6.  Evaluation of individual and combined applications of serum biomarkers for diagnosis of hepatocellular carcinoma: a meta-analysis.

Authors:  Bin Hu; Xiaohui Tian; Jie Sun; Xiangjun Meng
Journal:  Int J Mol Sci       Date:  2013-12-02       Impact factor: 5.923

Review 7.  The association of HMGB1 expression with clinicopathological significance and prognosis in hepatocellular carcinoma: a meta-analysis and literature review.

Authors:  Lu Zhang; Jianjun Han; Huiyong Wu; Xiaohong Liang; Jianxin Zhang; Jian Li; Li Xie; Yinfa Xie; Xiugui Sheng; Jinming Yu
Journal:  PLoS One       Date:  2014-10-30       Impact factor: 3.240

8.  Serum Biomarkers AFP, CEA and CA19-9 Combined Detection for Early Diagnosis of Hepatocellular Carcinoma.

Authors:  Muhammad Ibrahim Alhadi Edoo; Vikram Kumar Chutturghoon; Gyabaah Kwabena Wusu-Ansah; Hai Zhu; Tao Yang Zhen; Hai Yang Xie; Shu-Sen Zheng
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

Review 9.  The sweet and sour of serological glycoprotein tumor biomarker quantification.

Authors:  Uros Kuzmanov; Hari Kosanam; Eleftherios P Diamandis
Journal:  BMC Med       Date:  2013-02-07       Impact factor: 8.775

10.  An Overview of Biomarkers and Molecular Signatures in HCC.

Authors:  Seon-Hee Yim; Yeun-Jun Chung
Journal:  Cancers (Basel)       Date:  2010-05-07       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.